HydroGraph details progress and strategic outlook for fiscal 2025 and launches US$14 million private placement

In a recent shareholders letter, HydroGraph summarized its progress, company activity and plans as it enters Fiscal Year 2026.

HydroGraph reported on making significant progress in Fiscal 2025 across science, engineering, production, and sales to prepare for commercial sales of its 99.8% pure carbon fractal graphene products. The commercial sales pipeline includes over 65 projects spanning medical devices to large-scale markets like composites and coatings, with ongoing efforts to commercialize at scale.

In a recent shareholders letter, HydroGraph summarized its progress, company activity and plans as it enters Fiscal Year 2026.HydroGraph reported on making significant progress in Fiscal 2025 across science, engineering, production, and sales to prepare for commercial sales of its 99.8% pure carbon fractal graphene products. The commercial sales pipeline includes over 65 projects spanning medical devices to large-scale markets like composites and coatings, with ongoing efforts to commercialize at scale.

Read More Graphene-Info – Graphene industry portal